nach oben

Current Infectious Disease Reports

Erschienen in:

01.05.2010

What’s Behind the Increasing Rates of Coccidioidomycosis in Arizona and California?

verfasst von: Neil M. Ampel

Erschienen in: Current Infectious Disease Reports | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

The number of cases of symptomatic coccidioidomycosis reported in the endemic regions of California and Arizona has increased over the past two decades. In California, the southern San Joaquin Valley has seen a dramatic increase, with rates of symptomatic illness of more than 150 per 100,000 of population in Kern County. In Arizona, almost 5,000 cases are now reported yearly. In contrast to California, the coccidioidal endemic region in Arizona is also the most populous region of the state, and Arizona now accounts for 60% of all cases reported in the United States. Reasons for these increases appear to be multifactorial. Possible etiologies include climate change, changes in local exposure, an increase in the number of individuals susceptible to infection living in the endemic region, and increased testing and reporting. None of these factors are mutually exclusive and none has been clearly established as the etiology for the increase.

Albert BL, Sellers TF Jr: Coccidioidomycosis from fomites. Report of a case and review of the literature. Arch Intern Med 1963,112:253–261.PubMed

Gehlbach SH, Hamilton JD, Conant NF: Coccidioidomycosis. An occupational disease in cotton mill workers. Arch Intern Med 1973,131:254–255.CrossRefPubMed

Desai SA, Minai OA, Gordon SM, et al.: Coccidioidomycosis in non-endemic areas: a case series. Respir Med 2001, 95:305–309.CrossRefPubMed

Wanke B, Lazera M, Monteiro PC, et al.: Investigation of an outbreak of endemic coccidioidomycosis in Brazil’s northeastern state of Piaui with a review of the occurrence and distribution of Coccidioides immitis in three other Brazilian states. Mycopathologia 1999, 148:57–67.CrossRefPubMed

• Pappagianis D: Epidemiology of coccidioidomycosis. Curr Top Med Mycol 1988, 2:199–238. Despite being dated, this article is the most complete and comprehensive review of all the factors concerning the epidemiology of coccidioidomycosis and is required reading for anyone interested in this topic.PubMed

Fisher MC, Koenig GL, White TJ, Taylor JW: Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002, 94:73–84.CrossRef

Stewart RA, Meyer KF: Isolation of Coccidioides immitis (Stiles) from the soil. Proc Soc Exp Biol Med 1932, 29:937–938.

Pappagianis D, Zimmer BL: Serology of coccidioidomycosis. Clin Microbiol Rev 1990, 3:247–268.PubMed

Cole GT, Kirkland TN, Sun SH: An immunoreactive, water-soluble conidial wall fraction of Coccidioides immitis. Infect Immun 1987, 55:657–667.PubMed

10.

Shubitz L, Peng T, Perrill R, et al.: Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA. Infect Immun 2002, 70:3287–3289.CrossRefPubMed

11.

Edwards PQ, Palmer CE: Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and histoplasmin. Dis Chest 1957, 31:35–60.PubMed

12.

Ramras DG, Walch HA, Murray JP, Davidson BH: An epidemic of coccidioidomycosis in the Pacific beach area of San Diego. Am Rev Respir Dis 1970, 10:975–978.

13.

Rao S, Biddle M, Balchum OJ, Robinson JL: Focal endemic coccidioidomycosis in Los Angeles County. Am Rev Respir Dis 1972, 105:410–416.PubMed

14.

Werner SB, Pappagianis D, Heindl I, Mickel A: An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med 1972, 286:507–512.PubMed

15.

Petersen LR, Marshall SL, Barton-Dickson C, et al.: Coccidioidomycosis among workers at an archeological site, northeastern Utah. Emerg Infect Dis 2004,10:637–642.PubMed

16.

Smith CE, Beard RR, Whiting EG, Rosenberger HG: Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am J Public Health 1946, 36:1394–1402.CrossRefPubMed

17.

Levine HB, Gonzalez-Ochoa A, Ten Eyck DR: Dermal sensitivity to Coccidioides immitis. A comparison of responses elicited in man by spherulin and coccidioidin. Am Rev Respir Dis 1973, 107:379–386.PubMed

18.

Valdivia L, Nix D, Wright M, et al.: Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis 2006, 12:958–962.PubMed

19.

Pappagianis D: Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clin Infect Dis 1994,19(Suppl 1):S14–S18.PubMed

20.

Ampel NM, Mosley DG, England B, et al.: Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. Clin Infect Dis 1998, 27:1528–1530.CrossRefPubMed

21.

• Centers for Disease Control and Prevention: Increase in coccidioidomycosis—California, 2000–2007. MMWR Morb Mortal Wkly Rep 2009, 58:105–109. This article is a recent, well-written depiction of the current epidemic in California.

22.

Leake JA, Mosley DG, England B, et al.: Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996–1997. J Infect Dis 2000, 181:1435–1440.CrossRefPubMed

23.

Centers for Disease Control and Prevention: Increase in coccidioidomycosis—Arizona, 1998–2001. MMWR Morb Mortal Wkly Rep 2003, 52:109–112.

24.

Arizona Department of Health Services: Valley Fever Annual Report 2007. Phoenix, AZ: Office of Infectious Disease Services, Bureau of Epidemiology and Disease Control; 2008.

25.

Jacobs KL, Garfin GM, Morehouse BJ: Climate science and drought planning: the Arizona experience. J Am Water Resources Assoc 2005, 41:437–445.CrossRef

26.

Park BJ, Sigel K, Vaz V, et al.: An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998–2001. J Infect Dis 2005, 191:1981–1987.CrossRefPubMed

27.

Kolivras KN, Comrie AC: Modeling valley fever (coccidioidomycosis) incidence on the basis of climate conditions. Int J Biometeorol 2003, 47:87–101.PubMed

28.

Comrie AC: Climate factors influencing coccidioidomycosis seasonality and outbreaks. Environ Health Perspect 2005, 113:688–692.CrossRefPubMed

29.

Zender CS, Talamantes J: Climate controls on valley fever incidence in Kern County, California. Int J Biometeorol 2006, 50:174–182.CrossRefPubMed

30.

Talamantes J, Behseta S, Zender CS: Statistical modeling of valley fever data in Kern County, California. Int J Biometeorol 2007, 51:307–313.CrossRefPubMed

31.

McKinley J: Drought adds hardships in California. New York Times. February 21, 2009:A1.

32.

Flynn NM, Hoeprich PD, Kawachi MM, et al.: An unusual outbreak of windborne coccidioidomycosis. N Engl J Med 1979, 301:358–361.PubMedCrossRef

33.

Schneider E, Hajjeh RA, Spiegel RA, et al.: A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA 1997, 277:904–908.CrossRefPubMed

34.

Cairns L, Blythe D, Kao A, et al.: Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis 2000, 30:61–64.CrossRefPubMed

35.

Larwood TR: Coccidioidin skin testing in Kern County, California: decrease in infection rate over 58 years. Clin Infect Dis 2000, 30:612–613.CrossRefPubMed

36.

• Pappagianis D: Coccidioidomycosis in California state correctional institutions. Ann N Y Acad Sci 2007, 1111:103–111. This article describes a “perfect storm” of factors causing an outbreak of coccidioidomycosis.CrossRefPubMed

37.

Wohl AR, Johnson D, Jordan W, et al.: High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr 2000, 24:386–392.PubMed

38.

Rosenstein NE, Emery KW, Werner SB, et al.: Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995–1996. Clin Infect Dis 2001, 32:708–715.CrossRefPubMed

39.

Pappagianis D: Serologic studies in coccidioidomycosis. Semin Respir Infect 2001, 16:242–250.CrossRefPubMed

40.

Kaufman L, Sekhon AS, Moledina N, et al.: Comparative evaluation of commercial Premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. J Clin Microbiol 1995, 33:618–619.PubMed

41.

Zartarian M, Peterson EM, de la Maza LM: Detection of antibodies to Coccidioides immitis by enzyme immunoassay. Am J Clin Pathol 1997, 107:148–153.PubMed

42.

Blair JE, Currier JT: Significance of isolated positive IgM serologic results by enzyme immunoassay for coccidioidomycosis. Mycopathologia 2008, 166:77–82.CrossRefPubMed

Titel: What’s Behind the Increasing Rates of Coccidioidomycosis in Arizona and California?
verfasst von: Neil M. Ampel
Publikationsdatum: 01.05.2010
Verlag: Current Science Inc.
Erschienen in: Current Infectious Disease Reports / Ausgabe 3/2010
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-010-0094-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Influenza in Travelers: Epidemiology, Risk, Prevention, and Control Issues

Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine Development

Global Impact of Multidrug-Resistant Pulmonary Tuberculosis Among HIV-Infected and Other Immunocompromised Hosts: Epidemiology, Diagnosis, and Strategies for Management

Pulmonary Nontuberculous Mycobacterial Disease: New Insights into Risk Factors for Susceptibility, Epidemiology, and Approaches to Management in Immunocompetent and Immunocompromised Patients

Clinical Trials Report: Progress Toward an Effective Malaria Vaccine: RTS,S/ASO1B and RTS,S/ASO2A